|
|
| Research article summary (published 25 Aug 2009): |
Activation of the opioidergic descending pain control system underlies placebo analgesia.
Full Abstract
Placebo analgesia involves the endogenous opioid system, as administration of the opioid antagonist naloxone decreases placebo analgesia. To investigate the opioidergic mechanisms that underlie placebo analgesia, we combined naloxone administration with functional magnetic resonance imaging. Naloxone reduced both behavioral and neural placebo effects as well as placebo-induced responses in pain-modulatory cortical structures, such as the rostral anterior cingulate cortex (rACC). In a brainstem-specific analysis, we observed a similar naloxone modulation of placebo-induced responses in key structures of the descending pain control system, including the hypothalamus, the periaqueductal gray (PAG), and the rostral ventromedial medulla (RVM). Most importantly, naloxone abolished placebo-induced coupling between rACC and PAG, which predicted both neural and behavioral placebo effects as well as activation of the RVM. These findings show that opioidergic signaling in pain-modulating areas and the projections to downstream effectors of the descending pain control system are crucially important for placebo analgesia.
Author information
Author/s: Eippert, Falk (F); Bingel, Ulrike (U); Schoell, Eszter D (ED); Yacubian, Juliana (J); Klinger, Regine (R); Lorenz, Jürgen (J); Büchel, Christian (C);
Affiliation: Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. f.eippert(-atsign-)uke.uni-hamburg.de
Journal and publication information
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal: Neuron (Neuron), published in United States. (Language: eng)
Reference: 2009-Aug; vol 63 (issue 4) : pp 533-43
Dates: Created 2009/08/27; Completed 2009/09/21;
PMID: 19709634, status: MEDLINE (last retrieval date: 9/21/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Acetaminophen reinforces descending inhibitory pain pathways.
22 Oct 2007 - Alfentanil and placebo analgesia: no sex differences detected in models of experimental pain.
29 Jun 2005 - [Opiate receptors, endorphins and their antagonists]
29 Apr 1984 - Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
3 Apr 1991 - Opioid receptor activity in the dentate region of the rat hippocampus.
30 Dec 1985 - Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
5 Jun 2002 - Antinociceptive effects of alcohol and nicotine: involvement of the opioid system.
24 May 2006 - [Naloxone-reversible analgesia as a result of stimulation of the habenula in the rat]
30 Dec 1985 - Naloxone-reversible analgesia induced by electrical stimulation of the habenula in the rat.
15 Mar 1987 - Lack of reciprocity between opioid and 5-HT3 receptors for antinociception in rat spinal cord.
24 Jul 2006
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.